Icds, vads, and total artificial heart implantation

Abstract

Device therapy for heart failure has evolved rapidly over recent years and has become an important element in reducing mortality risk, improving quality of life and functional capacity for patients with heart failure. Therapies such as implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT) are aimed at reducing risk of sudden cardiac death and improving functional status. Heart failure is a progressive condition and, despite significant advances in medical therapy, may still develop into an end-stage state requiring consideration for advanced therapies such as mechanical circulatory support (MCS) and heart transplantation to prolong survival and improve quality of life. As with any procedure, each therapy poses its own risks and benefits which must be carefully weighed in each patient. Some, such as MCS, require significant psychosocial support in order to best achieve a positive outcome with maximal benefit to the patient.